P. Perrin

发表

Antiviral Drug Discovery Strategy Using Combinatorial Libraries of Structurally Constrained Peptides

P. Legrain, E. Réal, J. Rain, 2004, Journal of Virology.

Structural and immunogenic characteristics of rabies immunosomes.

P. Perrin, P. Sureau, L. Thibodeau, 1985, Developments in biological standardization.

Loss of the LAT adaptor converts antigen-responsive T cells into pathogenic effectors that function independently of the T cell receptor.

P. Perrin, R. Locksley, M. Mingueneau, 2009, Immunity.

Th2 Lymphoproliferative Disorder of LatY136F Mutant Mice Unfolds Independently of TCR-MHC Engagement and Is Insensitive to the Action of Foxp3+ Regulatory T Cells1

P. Perrin, M. Mingueneau, Stéphane Chevrier, 2008, The Journal of Immunology.

The antigen-specific cell-mediated immune response in mice is suppressed by infection with pathogenic lyssaviruses.

C. Jallet, P. Perrin, N. Tordo, 1996, Research in virology.

Interaction of lyssaviruses with the low-affinity nerve-growth factor receptor p75NTR.

C. Jallet, P. Perrin, N. Tordo, 2001, The Journal of general virology.

The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses

P. Perrin, J. Manuguerra, O. Merten, 1999, Cytotechnology.

A new family of carriers (biovectors) enhances the immunogenicity of rabies antigens.

P. Perrin, D. Betbeder, S. Morgeaux, 1996, Vaccine.

CD146 and its Soluble Form Regulate Monocyte Transendothelial Migration

P. Perrin, A. Le Bivic, F. Vély, 2009, Arteriosclerosis, thrombosis, and vascular biology.

Beta-propiolactone treatment impairs the biological activity of residual DNA from BHK-21 cells infected with rabies virus.

P. Perrin, N. Tordo, S. Morgeaux, 1993, Vaccine.

Immunization of dogs with a DNA vaccine induces protection against rabies virus.

C. Jallet, P. Perrin, N. Tordo, 1999, Vaccine.

Comparison of human immune responses to purified Vero cell and human diploid cell rabies vaccines by using two different antibody titration methods

P. Perrin, O. Olsvik, B. Johnson, 1990, Journal of clinical microbiology.

Toward a DNA Vaccine Against Lyssa Viruses

P. Perrin, N. Tordo, Y. Jacob, 1997 .

Stabilization and enhancement of interleukin-2 in vitro bioactivity by new carriers: supramolecular biovectors.

P. Perrin, C. Leclerc, O. Merten, 1994, Vaccine.

In vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibody.

P. Perrin, P. Sureau, S. Morgeaux, 1990, Biologicals : journal of the International Association of Biological Standardization.

Use of a monoclonal antibody for quantitation of rabies vaccine glycoprotein by enzyme immunoassay.

P. Perrin, P. Sureau, P. Versmisse, 1985, Journal of biological standardization.

Inactivated rabies vaccine control and release: use of an ELISA method.

C. Jallet, P. Perrin, N. Tordo, 2003, Biologicals : journal of the International Association of Biological Standardization.

Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine?

C. Jallet, P. Perrin, N. Tordo, 1999, Vaccine.

A new immunostimulatory complex (PICKCa) in experimental rabies: antiviral and adjuvant effects

P. Perrin, M. Saron, C. Gontier, 2005, Archives of Virology.

Interleukin 2 increases protection against experimental rabies.

P. Perrin, P. Sureau, L. Thibodeau, 1988, Immunobiology.

Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: Use of various cell lines

P. Perrin, O. Merten, N. Castignolles, 2004, Cytotechnology.

Cellular response to rabies virus infection.

F. Bussereau, P. Perrin, 1982, Comparative immunology, microbiology and infectious diseases.

DNA-Based Immunization against Lyssaviruses

P. Perrin, N. Tordo, Y. Jacob, 2001, Intervirology.

Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells.

P. Perrin, J. Davoust, B. Malissen, 2005, Immunity.

Differential stability and fusion activity of Lyssavirus glycoprotein trimers.

P. Perrin, N. Tordo, Y. Gaudin, 2003, Virus research.

An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system.

P. Perrin, N. Tordo, O. Merten, 1995, Vaccine.

Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins.

M. Prevost, P. Perrin, N. Tordo, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses.

P. Perrin, N. Tordo, Y. Jacob, 1998, Vaccine.

Interleukin-2 production in vitro: a new approach to the study of rabies vaccine immunogenicity as appraised by testing different glycoprotein presentations.

P. Perrin, P. Sureau, L. Thibodeau, 1988, Vaccine.

A rapid rabies enzyme immuno-diagnosis (RREID): a useful and simple technique for the routine diagnosis of rabies.

P. Perrin, P. Sureau, P. Rollin, 1986, Journal of biological standardization.

Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies.

P. Perrin, P. Sureau, L. Thibodeau, 1985, Vaccine.

Structure of the rabies virus: Spatial relationships of the proteins G, M1, M2 and N

P. Perrin, P. Atanasiu, J. Delagneau, 1981 .

Phage-displayed and soluble mouse scFv fragments neutralize rabies virus.

J. Guesdon, P. Perrin, N. Tordo, 1997, Journal of virological methods.

A modified rapid enzyme immunoassay for the detection of rabies and rabies-related viruses: RREID-lyssa.

P. Perrin, H. Bourhy, C. Gontier, 1992, Biologicals : journal of the International Association of Biological Standardization.

Enhancement of antigen-specific interleukin 2 production by adding liposomes to rabies antigens for priming.

P. Perrin, P. Sureau, L. Thibodeau, 1988, Immunology letters.

The association of the rabies glycoprotein with liposome (immunosome) induces an in vitro specific release of interleukin 2.

P. Perrin, P. Sureau, L. Thibodeau, 1987, Cellular immunology.

The use of various immunochemical, biochemical and biological methods for the analysis of rabies virus production in tissue cultures.

P. Perrin, P. Sureau, A. David, 1983, Developments in biological standardization.

Use of an enzyme immunoassay with protein A for rabies antigen and antibody determination.

P. Perrin, P. Atanasiu, J. Delagneau, 1980, Developments in biological standardization.

A collaborative study of an experimental kit for rapid rabies enzyme immunodiagnosis (RREID).

P. Perrin, P. Sureau, 1987, Bulletin of the World Health Organization.

Rabies: epidemiological tendencies and control tools.

C. Jallet, P. Perrin, N. Tordo, 2006, Developments in Biologicals.

RESIDUAL IN VITRO ACTIVITY OF DNA IN BIOLOGICALS TREATED BY BETA-PROPIOLACTONE: RABIES VACCINES AS MODEL

P. Perrin, N. Tordo, O. Merten, 1994 .

Appraisal of rabies vaccine potency by determination of in vitro, specific interleukin-2 production.

P. Perrin, P. Sureau, C. Leclerc, 1991, Biologicals : journal of the International Association of Biological Standardization.

The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virus.

P. Perrin, P. Sureau, P. Rollin, 1986, Journal of biological standardization.

Application d'une méthode immunoenzymatique au titrage des anticorps rabiques neutralisants en culture cellulaire

P. Perrin, P. Sureau, P. Versmisse, 1985 .

Rabies-specific production of interleukin-2 by peripheral blood lymphocytes from human rabies vaccinees.

P. Perrin, P. Sureau, C. Leclerc, 1991, Vaccine.

DNA-based immunisation against rabies and rabies-related viruses: towards multivalent vaccines.

P. Perrin, N. Tordo, Y. Jacob, 2000, Developments in biologicals.

The use of immunosome technology for vaccines against rabies and other viral diseases

P. Perrin, P. Sureau, 1989, European Journal of Epidemiology.

Enhancement of interleukin-2 activity by liposomes.

P. Perrin, P. Sureau, M. Joffret, 1990, Vaccine.

Evaluation of the induction of specific cytotoxic T lymphocytes following immunization of F1 hybrid mice with rabies antigens.

P. Perrin, P. Sureau, C. Leclerc, 1989, Research in virology.

Lyssavirus glycoproteins expressing immunologically potent foreign B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines.

P. Perrin, N. Tordo, Y. Jacob, 1999, The Journal of general virology.

PRODUCTION OF LYSSA VIRUS PROTEINS IN THE BACULOVIRUS EXPRESSION SYSTEM AND THEIR USE AS POTENTIAL VACCINE

C. Jallet, P. Perrin, N. Tordo, 1997 .

Scale-up of hydrophobic interaction chromatography for the purification of a DNA vaccine against rabies

P. Perrin, N. Tordo, M. M. Diogo, 2000, Biotechnology Letters.

Production, purification and analysis of an experimental DNA vaccine against rabies

P. Perrin, N. Tordo, M. M. Diogo, 2001, The journal of gene medicine.

Chimeric Lyssavirus Glycoprotein: New Vector for Multivalent Vaccines

P. Perrin, N. Tordo, Y. Jacob, 1999 .

Inactivation of DNA by β-propiolactone

P. Perrin, S. Morgeaux, 1995 .

Regulatory T Cells + to the Action of Foxp 3 of TCR-MHC Engagement and Is Insensitive Mutant Mice Unfolds Independently Y 136 F Lat Th 2 Lymphoproliferative Disorder of

P. Perrin, M. Mingueneau, Stéphane Chevrier, 2008 .

[Demonstration of sialic acid in the rabies virus. Consequences of its removal on infectious and hemagglutinating properties].

P. Perrin, P. Atanasiu, H. Tsiang, 1976, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles.

A rabies agglutination test (RAT) for rabies antibody detection.

P. Perrin, P. Sureau, P. Versmisse, 1988, Journal of biological standardization.

Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients

P. Perrin, C. June, A. Lovett-racke, 1998, Journal of Neuroimmunology.

New Developments and New Applications in Animal Cell Technology

Otto-Wilhelm Merten, Pierre Perrin, Bryan Griffiths, 2002, Springer Netherlands.

Compositions based on a combination of liposomes and lymphokine presenting immunostimulating properties and their applications in human and veterinary medicine

P. Perrin, P. Sureau, C. Leclerc, 1987 .

Complex 4q35 and 10q26 Rearrangements

P. Perrin, F. Magdinier, R. Bernard, 2023, Neurology: Genetics.

Inactivation of DNA by beta-propiolactone.

P. Perrin, S. Morgeaux, 1995, Biologicals : journal of the International Association of Biological Standardization.